Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Cocrystal Pharma, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 35 | 34 | −1 |
| Shares | 15.1M | 14.4M | −686.4K (−4.6%) |
| Value | $9.78M | $7.90M | −$1.88M (−19.2%) |
New holders (6)
Institutions that held Cocrystal Pharma, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Western Wealth Management, LLC | 22,815 | $13.0K | 0.00% |
| Susquehanna International Group, LLP | 16,129 | $9.00K | 0.00% |
| Virtu Financial LLC | 14,237 | $8.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 8,415 | $5.00K | 0.00% |
| Joseph P. Lucia & Associates, LLC | 200 | $0 | 0.00% |
| Quent Capital, LLC | 266 | $0 | 0.00% |
Sold out (7)
Institutions that held Cocrystal Pharma, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| LPL Financial LLC | 200,250 | $130.0K |
| Two Sigma Securities, LLC | 39,667 | $26.0K |
| Dimensional Fund Advisors LP | 32,216 | $21.0K |
| Goldman Sachs Group Inc | 17,675 | $11.0K |
| Jane Street Group, LLC | 13,158 | $9.00K |
| Lanham O'Dell & Company, Inc. | 12,000 | $8.00K |
| Barclays PLC | 150 | $0 |